公司动态近期,港交所上市企业康哲药业发布公告称,计划将旗下专注于皮肤业务的子公司德镁医药的股份进行分拆,并在香港联交所主板实现独立上市。公告表明,康哲药业持有德镁医药90.8%的股权,其余9.2%的股权由两家雇员激励平台持有。据悉,此次分拆预计采用实物分派的方式,康哲药业将把所持有的全部德镁医药股份,按照比例无偿分派给现有股东。 公开资料显示,德镁医药成立于2020年,是一家聚焦于皮肤健康的创新型...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.